Low molecular weight heparin reduces arterial blood lactic acid content and increases estimated glomerular filtration rate in patients with moderate Covid-19 pneumonia

BACKGROUND: Coronavirus disease 2019 (Covid-19) remains a serious health threat worldwide. We aimed to investigate whether low molecular weight heparin (LMWH) can promote organ function recovery in moderate Covid-19 pneumonia patients. METHODS: We initiated an LMWH protocol in Covid-19 patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Li, Zeng, Yigang, Zhao, Bing, Xu, Lili, Li, Jian, Zhu, Tongyu, Mao, Enqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276367/
https://www.ncbi.nlm.nih.gov/pubmed/35471480
http://dx.doi.org/10.1097/CM9.0000000000001923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276367/
https://www.ncbi.nlm.nih.gov/pubmed/35471480
http://dx.doi.org/10.1097/CM9.0000000000001923

Ejemplares similares